Hormone Therapy can Put Transgenders at Risk of Heart Disease: Study

by Rishika Gupta on  August 4, 2018 at 6:49 PM Lifestyle News
RSS Email Print This Page Comment bookmark
Font : A-A+

Heart Disease Risk Higher in Transgender Individuals finds a new study. This increased risk may be due to the hormone therapy that transgender people have to take for masculinization or feminization.
 Hormone Therapy can Put Transgenders at Risk of Heart Disease: Study
Hormone Therapy can Put Transgenders at Risk of Heart Disease: Study

The findings of this study are published in the Reviews in Endocrine and Metabolic Disorders journal.

A review authored by Michael S. Irwig, MD, associate professor of medicine at the George Washington University (GW) School of Medicine and Health Sciences and director of the Andrology Center at the GW Medical Faculty Associates, examined several studies that followed transgender individuals on hormone therapy.

"Many transgender patients take either testosterone or estrogen for masculinization or feminization," explained Irwig. "Some studies have suggested that transgender people have an increased risk for heart attack and death due to cardiovascular disease."

The review focuses on cardiovascular events (myocardial infarction, stroke and venous thromboembolism) and surrogate markers -- including blood pressure and lipid concentrations -- in transgender patients on hormone therapy who may or may not have undergone gender affirmation procedures. The studies that the review covers show that transgender women appear to have increased risk for cardiovascular events due to hormone therapy whereas the data is unclear for transgender men. It is well known that estrogen therapy for trans women increases their risk of blood clots (deep venous thromboses).

"In clinical studies that followed transgender patients, rates for myocardial infarction were consistently higher in transgender women on estrogen therapy than in transgender men on testosterone," Irwig said. "The relationship between endogenous sex hormones and heart disease is complex. In cisgender women, estrogen may have a protective effect."

Given that hormone therapy is often essential in the management of transgender patients, Irwig suggests that more research is needed on the effects and risk of hormone therapy in older transgender populations and on the safest forms of estrogen therapy.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Reiki and Pranic Healing Heart Healthy Heart Statins Mitral Valve Prolapse Aortic Valve Stenosis Pericarditis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive